Anti-CD45RB monoclonal antibodyAlternative Names: Anti-CD45RB monoclonal antibody MB23G2; Monoclonal antibody MB23G2
Latest Information Update: 16 Apr 2007
At a glance
- Originator Amgen; University of Groningen; University of Western Ontario
- Class Monoclonal antibodies
- Mechanism of Action CD45 antigen inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Transplant rejection